power

The Court Took Away the President's Tariff Gun. He's Already Looking for Another One.

What happened

The Supreme Court ruled in February 2026 that the president cannot use the International Emergency Economic Powers Act to impose tariffs, striking down $166 billion in trade levies. By April, the Trump administration was threatening new 50% tariffs on multiple countries without citing any specific legal authority, suggesting either a bluff or a willingness to force another Supreme Court confrontation.

The Supreme Court handed Congress back its trade authority in February, and by April the executive branch was already trying to take it back. this time with no named legal hook, which either means the threat is a bluff or the administration is willing to test the Court again.

The Hidden Bet

The SCOTUS ruling resolved the question of executive tariff authority. the Court said no, so the president's broad tariff power is gone.

Roberts' majority opinion closed the IEEPA door but left Section 232 (national security tariffs) and Section 122 (emergency balance-of-payments authority) alive. The administration is actively using both, and the legal perimeter of each is still being litigated. The ruling constrained one tool, not all tools.

Tariffs as a trade policy tool failed. the empirical record after a year shows they didn't work, which is why the Court stepped in.

The Court's ruling was on constitutional authority, not on economic effectiveness. Roberts' opinion explicitly said nothing about whether tariffs are good or bad policy. only that this president lacked the statutory power to impose them this way. The political will to use tariffs has not diminished; only the legal vehicle changed.

Congress will reassert its trade authority now that the Court has invited it to.

Congress has consistently delegated trade authority to the executive since the 1930s because tariff politics are toxic. every trade action creates losers who lobby against it. The Court ruling creates an opening for Congress to act, but the incentive structure for Congress to actually use it is weak.

The Real Disagreement

The real fork is whether the constitutional limits on executive trade authority that SCOTUS just reasserted will actually hold in practice, or whether the administration will find enough residual statutory authority. Section 232, Section 122, pharmaceutical and defense-sector carve-outs. to reconstruct a functionally equivalent tariff regime without IEEPA. The optimistic read: the Court drew a line that will force trade policy back through Congress, restoring democratic accountability. The pessimistic read: the line applies to IEEPA specifically, and a president willing to issue social-media tariff threats with no cited legal authority is already probing what else is available. I lean toward the pessimistic read. the demand for executive trade flexibility hasn't changed, only the legal costume has to.

What No One Is Saying

The $166 billion in tariff refunds ordered by the Court represent money that was collected, spent, and is now owed back to importers. but the federal government does not actually have a mechanism to quickly return that money. The refund process will take years, and some of the downstream cost was already passed to consumers in the form of higher prices that will never be reversed. The consumers who paid elevated prices for Chinese goods in 2025 are not getting a check.

Who Pays

US importers of finished goods with metal components

Immediate, effective April 6

The Section 232 restructuring effective April 6 shifted from tariffs on embedded metal content to tariffs on full product value. a product with $10 of steel in a $200 assembly now has a tariff base of $200, not $10. For industries like automotive parts and industrial equipment, total duty burden increases even as the headline rate looks similar.

Countries that sell branded pharmaceuticals to the US

Escalating over 12-24 months as enforcement builds

100% tariffs on branded pharmaceutical imports from countries that lack US production or won't cut prices. a direct revenue weapon aimed at European and Japanese pharma exporters and designed to force manufacturing onshoring.

Countries that supplied Iran with weapons

Conditional; depends on legal mechanism being identified

If Trump's threatened 50% tariffs are actually implemented. which requires a named legal vehicle the announcement didn't provide. Russia and China face new trade pressure, but their imports to the US are already minimal enough that the leverage is asymmetric.

Scenarios

Rebuild Via Congress

The administration works with Republican leadership to pass a narrow trade authority bill that codifies tariff powers the Court just invalidated, effectively superseding the ruling through legislation. The tariff regime returns, but now with democratic imprimatur.

Signal Senate Finance Committee schedules hearings on trade authority within 60 days of the ruling

Death by a Thousand Section 232s

The administration uses every remaining statutory authority. Section 232 national security tariffs, pharmaceutical tariffs, executive orders invoking new emergency frameworks. to rebuild something functionally equivalent to the IEEPA regime, sector by sector, daring courts to challenge each one individually.

Signal A new executive order invoking national security authority on a broad category of imports within 30 days of the ruling

Court Line Holds

Lower courts apply the Roberts ruling aggressively to block Section 122 and pharmaceutical tariffs on the same logic. emergency economic tools cannot substitute for congressional authorization. The executive's trade arsenal is genuinely constrained for the first time in decades.

Signal A federal circuit court applies Learning Resources logic to a non-IEEPA tariff within 90 days

What Would Change This

If Trump's post-ceasefire 50% tariff threat on Iran-weapons suppliers gets formally implemented through a named statutory authority that courts uphold, then the IEEPA ruling was narrower than it appeared and executive trade power is largely intact. That would flip the bottom line entirely.